Sign Up Today and Learn More About Pharos iBio Co. Stock
Invest in or calculate the value of your shares in Pharos iBio Co. or other pre-IPO companies through EquityZen's platform.
Pharos iBio Co. Stock (PIBC)
Pharos iBio Co. specializing in drug development that develops treatments for intractable diseases.
About Pharos iBio Co. Stock
Founded
2016
Industries
Software, Artificial Intelligence, Data and Analytics
Pharos iBio Co. Press Mentions
Stay in the know about the latest news on Pharos iBio Co.
Preventive, relief or therapeutic use of 2,3,5-substituted thiophene compound …
patents • May 04, 2025
Composition for combination therapy, comprising 2,3,5-substituted thiophene …
patents • Feb 11, 2025
Use of 2,3,5-substituted thiophene compound for preventing, alleviation, or …
patents • Feb 11, 2025
Pharos Ibio wins MFDS orphan drug designation for AML drug
bioworld • Sep 07, 2024
Pharos iBio Co., Ltd. (388870.KQ) Recent Insider Transactions
finance • Aug 03, 2024
Join now and verify your accreditation status to gain access to:
- Pharos iBio Co. Current Valuation
- Pharos iBio Co. Stock Price
- Pharos iBio Co. Management
- Available deals in Pharos iBio Co. and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Pharos iBio Co. Cap Table and Funding History by Share Class and Liquidity Preferences
- Pharos iBio Co. Revenue and Financials
- Pharos iBio Co. Highlights
- Pharos iBio Co. Business Model
- Pharos iBio Co. Risk Factors
- Pharos iBio Co. Research Report from SACRA Research
Trading Pharos iBio Co. Stock
How to invest in Pharos iBio Co. stock?
Accredited investors can buy pre-IPO stock in companies like Pharos iBio Co. through EquityZen funds. These investments are made available by existing Pharos iBio Co. shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Pharos iBio Co. stock?
Shareholders can sell their Pharos iBio Co. stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
